NCT02153229.

Trial name or title	A randomised phase 2 Trial of radical pleurectomy and post‐operative chemotherapy with or without intraoperative porfimer sodium ‐mediated photodynamic therapy for patients with epitheliod malignant pleural mesothelioma
Methods	Randomised phase II
Participants	Participants with histologically confirmed mesothelioma and disease confined to one hemithorax
Interventions	Experimental arm 1: chemotherapy plus radical pleurectomy plus photodynamic therapy Experimental arm 2: chemotherapy plus radical pleurectomy
Outcomes	Primary Outcome Measures: Number of adverse events (time frame: 4 years)
Starting date	May 2014
Contact information	Sally.Mcnulty@uphs.upenn.edu
Notes	Sponsor: Abramson Cancer Center of the University of Pennsylvania